128 related articles for article (PubMed ID: 386266)
1. [Artificial pancreas: clinical and therapeutic value in 11 patients (author's transl)].
Buysschaert M; Lambotte L; Lambert AE
Nouv Presse Med; 1979 Jul 14-28; 8(32):2597-601. PubMed ID: 386266
[TBL] [Abstract][Full Text] [Related]
2. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
[TBL] [Abstract][Full Text] [Related]
3. [The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)].
Schatz H; Pfeiffer EF
MMW Munch Med Wochenschr; 1976 Apr; 118(16):485-92. PubMed ID: 818514
[TBL] [Abstract][Full Text] [Related]
4. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.
Brunetti P; Massi-Benedetti M; Puxeddu A; Santeusanio F; Calabrese G; Bolli G; Scionti L; Angeletti G
Horm Metab Res Suppl; 1979; (8):81-6. PubMed ID: 395095
[TBL] [Abstract][Full Text] [Related]
5. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
Lambert AE; Buysschaert M; Lambotte L
Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
[No Abstract] [Full Text] [Related]
6. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
Neuhaus C; Kerner W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
[TBL] [Abstract][Full Text] [Related]
7. [The normalisation of blood sugar using a non-miniaturised artifical pancreas. Application for 24 hours in 7 insulin-dependent diabetics (author's transl)].
Slama G; Klein JC; Tardieu MC; Tchobroutsky G
Nouv Presse Med; 1977 Jun; 6(26):2309-13. PubMed ID: 887415
[TBL] [Abstract][Full Text] [Related]
8. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
Kerner W; Beischer W; Maier V; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
[TBL] [Abstract][Full Text] [Related]
9. [Insulin treatment of decompensated diabetes mellitus with a new artificial endocrine pancreas (author's transl)].
Kerner W; Beischer W; Tamás G; Raptis S; Pfeiffer EF
Dtsch Med Wochenschr; 1977 Oct; 102(42):1500-5. PubMed ID: 334502
[TBL] [Abstract][Full Text] [Related]
10. [Artificial endocrine pancreas (author's transl)].
Kruse-Jarres JD
J Clin Chem Clin Biochem; 1979 Jul; 17(7):457-63. PubMed ID: 383880
[TBL] [Abstract][Full Text] [Related]
11. [Artificial pancreas: study methods and control of glycemia equilibrium in diabetic patients].
Altomare E; Moulin JP; Vialettes B; Bourelly N; Vague P
Boll Soc Ital Biol Sper; 1979 May; 55(10):961-6. PubMed ID: 508411
[TBL] [Abstract][Full Text] [Related]
12. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
Mirouze J; Selam JL; Pham TC; Orsetti A
Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
[TBL] [Abstract][Full Text] [Related]
13. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas.
Drouin P; Rousselle D; Pointel JP; Voisin G; Stoltz JF; Clemens AH; Debry G
Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064
[TBL] [Abstract][Full Text] [Related]
14. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
[No Abstract] [Full Text] [Related]
15. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB
Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
[TBL] [Abstract][Full Text] [Related]
16. [The influence of blood glucose on the filtrability of red cells in diabets. Variations after connection to an artificial pancreas (author's transl)].
Juhan I; Buonocore M; Vovan L; Durand F; Calas MF; Moulin JP; Vague P
Nouv Presse Med; 1979 Dec; 8(50):4083-5. PubMed ID: 530823
[TBL] [Abstract][Full Text] [Related]
17. [Plasma lipid fractions in insulin-dependent diabetic patients. Effects of short-term control of glycaemia (author's transl)].
Vialettes B; Cartouzou G; Berge-Lefranc JL; Moulin JP; Vague P
Nouv Presse Med; 1981 Jun; 10(26):2185-92. PubMed ID: 7022366
[TBL] [Abstract][Full Text] [Related]
18. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
[TBL] [Abstract][Full Text] [Related]
19. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
Kerner W; Beischer W; Herfarth C; Pfeiffer EF
Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
[TBL] [Abstract][Full Text] [Related]
20. Continuous intravenous insulin therapy with a miniaturized open-loop system.
Renner R; Hepp KD; Mehnert H; Franetzki M
Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
